Jpmorgan Chase & CO Neuronetics, Inc. Put Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding STIM
# of Institutions
50Shares Held
13.1MCall Options Held
30.1KPut Options Held
0-
Kent Lake Pr LLC Anasco, PR2.08MShares$2.02 Million0.63% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$1.69 Million1.44% of portfolio
-
Cannell Capital LLC Alta, WY1.31MShares$1.27 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.3MShares$1.26 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA1.2MShares$1.16 Million0.05% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $26.2M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...